HM International Holdings Ltd

HM International Holdings Ltd

HHKEX:8416
0.11
HKD
-0.02
(-13.71%)
58.16MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.42
0.53
0.4
0.37
0.33
0.33
0.3
0.43
0.48
0.43
0.39
0.32
- -
Basic EPS, GAAP
0.04
0.05
0.04
0.02
0.02
0.01
-0.01
0.01
0.02
0.02
-0.02
0.02
- -
Free Cash Flow per Basic Share
0.05
- -
0.08
-0.01
0.01
0.03
0.04
0.05
0.04
0.08
-0.02
0.04
- -
Dividend per Share
- -
0.11
0.02
- -
0.03
- -
- -
- -
0.01
0.02
0.02
- -
- -
Book Value per Share
0.06
0.05
0.06
0.22
0.21
0.22
0.21
0.22
0.23
0.22
0.18
0.19
0.21
Tangible Book Value per Share
0.06
0.04
0.06
0.22
0.21
0.22
0.18
0.2
0.22
0.21
0.18
0.19
0.2
Basic Weighted Avg Shares
300
300
400
397
400
400
400
400
400
413
405
418
417
Sales/Revenue/Turnover
125
160
160
149
131
131
120
173
190
179
159
132
- -
Operating Margin (%)
10.96
11.71
11.83
8.28
6.25
4.52
-1.9
3.56
5.1
1.3
-4.62
-1.74
- -
Depreciation Expense
4
3
3
3
4
8
14
15
14
12
11
7
- -
Net Income, GAAP
11
14
15
10
7
3
-5
4
7
6
-8
8
- -
Effective Tax Rate (%)
13.7
20.92
20.15
20.23
12.09
35.7
- -
- -
3.12
0.93
- -
4.7
- -
Profit Margin (%)
8.67
8.65
9.35
6.68
5.48
2
-3.79
2.25
3.73
3.51
-4.86
5.92
- -
Working Capital
23
15
22
76
77
69
48
59
63
79
61
71
74
LT Debt
- -
1
- -
- -
- -
16
8
- -
6
- -
13
9
19
Total Equity
28
18
25
88
85
88
81
85
89
90
73
80
88
Return on Invested Capital (%)
- -
52.81
55.23
17.34
8.42
3.35
- -
- -
7.7
5.32
- -
2.81
- -
Return on Capital (%)
- -
47.92
58.34
17.48
8.28
3.76
- -
- -
7.77
6.63
- -
9.48
- -
Return on Common Equity (%)
- -
62.76
69.01
17.6
8.29
3.03
-5.29
4.55
7.95
6.84
-9.16
9.96
- -

Capital Structure

HKD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
ST Debt
- -
7
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
19
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
421
421
421
Market Capitalization
40
40
58

Working Capital

HKD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
Total Current Assets
- -
130
120
Cash, Cash Equivalents & STI
- -
91
62
Accounts Receivable, Net
- -
26
23
Inventories
- -
- -
- -
Total Current Liabilities
- -
51
46
Payables & Accruals
- -
- -
- -
ST Debt
- -
7
1
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28.17%
0.42%
10.5%
Free Cash Flow
199.43%
-55.92%
-280.46%
Net Income, GAAP
-92.97%
-107.88%
-201.44%
Sales/Revenue/Turnover
-0.72%
4.16%
-16.73%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
159
2025
- -
- -
132
2026
- -
- -
- -

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.02
2025
- -
- -
0.02
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.02
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Wai Lin Chan
Full Time Employees
112
Sector
Commercial services
Industry
Commercial printing/Forms
Address
Dah Sing Financial Centre Hong Kong Hong Kong
IPO Date
Jan 11, 2017
Business
HM International Holdings Limited is engaged primarily in the manufacturing and sale of medical protective equipment and related products. The company's core product portfolio includes medical protective masks, disposable medical gowns, isolation gowns, surgical drapes, medical caps, shoe covers, and other disposable personal protective equipment (PPE). It also offers face masks for general use. HM International Holdings operates its manufacturing and distribution businesses mainly in Hong Kong, mainland China, and internationally. Founded in 2003, the company is headquartered in Hong Kong. Recent major company developments include strategic expansions in production capacity to meet growing global demand for medical protective products, alongside continuous product innovation and diversification in PPE offerings. The company has focused on strengthening its supply chain and distribution network across Asia and other regions to capitalize on ongoing health and safety market trends. Its latest operational changes highlight a focus on enhancing product quality and entering new markets through partnerships and streamlined manufacturing processes, reflecting responsiveness to post-pandemic market conditions. HM International Holdings serves a broad customer base including hospitals, healthcare institutions, industrial clients, and retail markets across its geographic operations. It positions itself within the healthcare manufacturing industry segment, with a robust emphasis on quality control and regulatory compliance for medical devices. The company's ongoing innovations and strategic adjustments underpin its commitment to maintaining a leading position as a PPE provider globally.